Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 5 |
| NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4I173
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.620 |
| CLV_NRD_NRD_1 | 87 | 89 | PF00675 | 0.496 |
| CLV_PCSK_FUR_1 | 85 | 89 | PF00082 | 0.491 |
| CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.686 |
| CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.496 |
| DEG_APCC_DBOX_1 | 45 | 53 | PF00400 | 0.516 |
| DOC_MAPK_gen_1 | 46 | 53 | PF00069 | 0.486 |
| DOC_MAPK_MEF2A_6 | 34 | 41 | PF00069 | 0.550 |
| DOC_MAPK_MEF2A_6 | 46 | 55 | PF00069 | 0.417 |
| DOC_MAPK_NFAT4_5 | 34 | 42 | PF00069 | 0.454 |
| DOC_USP7_UBL2_3 | 25 | 29 | PF12436 | 0.561 |
| DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.599 |
| DOC_WW_Pin1_4 | 39 | 44 | PF00397 | 0.521 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.634 |
| LIG_BRCT_BRCA1_1 | 62 | 66 | PF00533 | 0.332 |
| LIG_FHA_2 | 40 | 46 | PF00498 | 0.535 |
| LIG_GBD_Chelix_1 | 53 | 61 | PF00786 | 0.555 |
| LIG_SH2_CRK | 80 | 84 | PF00017 | 0.662 |
| LIG_Sin3_3 | 54 | 61 | PF02671 | 0.356 |
| LIG_TYR_ITIM | 78 | 83 | PF00017 | 0.568 |
| MOD_CDK_SPK_2 | 24 | 29 | PF00069 | 0.560 |
| MOD_CDK_SPxxK_3 | 39 | 46 | PF00069 | 0.542 |
| MOD_CK1_1 | 23 | 29 | PF00069 | 0.590 |
| MOD_CK2_1 | 24 | 30 | PF00069 | 0.541 |
| MOD_CK2_1 | 39 | 45 | PF00069 | 0.545 |
| MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.836 |
| MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.794 |
| MOD_GlcNHglycan | 30 | 34 | PF01048 | 0.739 |
| MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.436 |
| MOD_GSK3_1 | 16 | 23 | PF00069 | 0.585 |
| MOD_GSK3_1 | 35 | 42 | PF00069 | 0.404 |
| MOD_NEK2_1 | 37 | 42 | PF00069 | 0.442 |
| MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.598 |
| MOD_ProDKin_1 | 39 | 45 | PF00069 | 0.516 |
| TRG_DiLeu_BaEn_1 | 45 | 50 | PF01217 | 0.515 |
| TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.724 |
| TRG_ER_diArg_1 | 85 | 88 | PF00400 | 0.688 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3Q8ID69 | Leishmania donovani | 99% | 100% |
| E9AIR4 | Leishmania braziliensis | 61% | 100% |
| E9AXA7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
| Q4QA65 | Leishmania major | 87% | 100% |